Status:
TERMINATED
The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
An important subgroup of protein-bound toxins are generated as a result of protein fermentation in the colon. P-cresol is a fermentation metabolite of tyrosine. In renal failure, the colonic generatio...
Eligibility Criteria
Inclusion
- Age \> 18
- Exit site infection, requiring antibiotic treatment
- Maintenance therapy with peritoneal dialysis
Exclusion
- Signs of peritonitis
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00433342
Start Date
March 1 2006
End Date
April 1 2020
Last Update
April 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitaire Ziekenhuizen Leuven
Leuven, Vlaams-Brabant, Belgium, 3000